As of 2025-06-02, the Relative Valuation of Astrazeneca Pharma India Ltd (ASTRAZEN.NS) is 1,956.95 INR. This relative valuation is based on P/E multiples. With the latest stock price at 7,980.00 INR, the upside of Astrazeneca Pharma India Ltd based on Relative Valuation is -75.5%.
The range of the Relative Valuation is 1,186.90 - 2,678.58 INR.
| Range | Selected | |
| Trailing P/E multiples | 30.6x - 40.0x | 35.8x |
| Forward P/E multiples | 27.4x - 32.0x | 30.2x |
| Fair Price | 1,186.90 - 2,678.58 | 1,956.95 |
| Upside | -85.1% - -66.4% | -75.5% |
| Date | P/E |
| 2025-05-30 | 205.53 |
| 2025-05-29 | 203.67 |
| 2025-05-28 | 202.64 |
| 2025-05-27 | 203.61 |
| 2025-05-26 | 207.54 |
| 2025-05-23 | 204.25 |
| 2025-05-22 | 206.25 |
| 2025-05-21 | 204.45 |
| 2025-05-20 | 203.85 |
| 2025-05-19 | 205.48 |
| 2025-05-16 | 202.26 |
| 2025-05-15 | 204.94 |
| 2025-05-14 | 207.54 |
| 2025-05-13 | 210.27 |
| 2025-05-12 | 208.78 |
| 2025-05-09 | 206.07 |
| 2025-05-08 | 209.67 |
| 2025-05-07 | 210.38 |
| 2025-05-06 | 212.44 |
| 2025-05-05 | 214.12 |
| 2025-05-02 | 215.28 |
| 2025-04-30 | 223.29 |
| 2025-04-29 | 226.41 |
| 2025-04-28 | 228.91 |
| 2025-04-25 | 224.31 |
| 2025-04-24 | 230.62 |
| 2025-04-23 | 233.40 |
| 2025-04-22 | 230.53 |
| 2025-04-21 | 225.12 |
| 2025-04-17 | 224.35 |
| 2025-04-16 | 219.14 |
| 2025-04-15 | 228.45 |
| 2025-04-11 | 218.59 |
| 2025-04-09 | 207.15 |
| 2025-04-08 | 207.80 |
| 2025-04-07 | 204.41 |
| 2025-04-04 | 204.19 |
| 2025-04-03 | 206.87 |
| 2025-04-02 | 208.75 |
| 2025-04-01 | 218.37 |
| 2025-03-28 | 221.10 |
| 2025-03-27 | 219.14 |
| 2025-03-26 | 216.56 |
| 2025-03-25 | 216.56 |
| 2025-03-24 | 217.85 |
| 2025-03-21 | 221.72 |
| 2025-03-20 | 215.96 |
| 2025-03-19 | 203.67 |
| 2025-03-18 | 203.55 |
| 2025-03-17 | 198.52 |